Related Experiment Videos
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric
Simone Zuccotti1, Camillo Rosano, Palma Mangione
1Department of Physics-INFM and Center of Excellence for Biomedical Research, University of Genova, Via Dodecaneso 33, 16146 Genova, Italy.
Abstract:
Patients receiving prolonged haemodialysis treatment are exposed to a variety of arthropathies and bone lesions arising from deposition of amyloid material in the skeletal system. beta2 microglobulin is the 11.7 kDa light chain of the class I major histocompatibility complex, from which it is normally released to plasmatic fluids, transported to kidneys and excreted. Owing to renal failure it accumulates, giving rise to dialysis-related amyloidosis, a severe disease found in patients receiving dialysis for several years. The three-dimensional structure of beta2 microglobulin is known to be based on a seven-stranded beta-sandwich fold, typical of the class C immunoglobulin superfamily. Analysis of the protein fold in different mutants and/or crystal environments and of its structural stability may help in understanding the molecular bases of amyloid fibril formation and of diseases related to protein misfolding. Here, the preliminary crystallographic analysis of the His31Tyr beta2 microglobulin mutant, designed to abolish the copper-ion binding observed in the wild-type protein, is presented. The protein mutant displays increased fold stability, faster folding kinetics and crystallizes in the tetragonal C222(1) space group, with unit-cell parameters a = 105.2, b = 150.2, c = 93.7 A and four molecules per asymmetric unit.
Insights
Dialysis-related amyloidosis occurs in patients with renal failure due to beta2 microglobulin accumulation. A His31Tyr mutant shows increased stability, aiding research into protein misfolding diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Medical Science
Background:
- Patients on long-term hemodialysis can develop amyloidosis from beta2 microglobulin deposition.
- Beta2 microglobulin, a component of MHC class I, accumulates in renal failure, causing dialysis-related amyloidosis.
- Understanding beta2 microglobulin's structure and stability is crucial for studying amyloid fibril formation and protein misfolding diseases.
Purpose of the Study:
- To present the preliminary crystallographic analysis of the His31Tyr beta2 microglobulin mutant.
- To investigate the structural and stability changes in a mutant designed to eliminate copper-ion binding.
- To contribute to understanding the molecular basis of amyloidosis and protein misfolding.
Main Methods:
- Preliminary crystallographic analysis of the His31Tyr beta2 microglobulin mutant.
- Characterization of protein fold stability and folding kinetics.
- X-ray diffraction to determine crystal structure and unit-cell parameters.
Main Results:
- The His31Tyr mutant exhibits enhanced fold stability and faster folding kinetics compared to wild-type.
- The mutant protein crystallizes in the tetragonal C222(1) space group.
- Unit-cell parameters were determined as a = 105.2, b = 150.2, c = 93.7 A, with four molecules per asymmetric unit.
Conclusions:
- The His31Tyr mutation impacts beta2 microglobulin stability and folding.
- This structural data provides insights into the molecular mechanisms of amyloid formation.
- Further studies on this mutant can elucidate pathways leading to dialysis-related amyloidosis.